SCHEMBL6414716

SCHEMBL6414716

COC(=O)NC(CCN1CCC2(CC1)CCN(Cc1cccnc1)C2=O)c1ccc(OC)c(OC)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
POLB P06746 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
MAPT P10636 1/20 0.41
USP2 O75604 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
QPCT Q16769 1/20 0.40
ROCK2 O75116 1/20 0.39
ROCK1 Q13464 1/20 0.39
PDE4B Q07343 2/20 0.38
PDE4A P27815 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
HCRTR2 O43614 1/20 0.38
KMT2A Q03164 3/20 0.38
TDP1 Q9NUW8 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PTAFR P25105 1/20 0.38
MEN1 O00255 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6414711 0.99 ALDH1A1 (0.43) ALDH1A1POLBL3MBTL1MAPTUSP2
SCHEMBL6417321 0.94 ALDH1A1 (0.48) ALDH1A1POLBL3MBTL1MAPTUSP2
Hydrochloric Acid SCHEMBL6417316 0.93 ALDH1A1 (0.47) ALDH1A1POLBL3MBTL1MAPTUSP2
SCHEMBL6409263 0.91 ROCK2 (0.49) ALDH1A1POLBMAPTROCK2ROCK1
Hydrochloric Acid SCHEMBL6409256 0.90 ROCK2 (0.48) ALDH1A1POLBMAPTROCK2ROCK1
SCHEMBL6417656 0.88 POLB (0.41) ALDH1A1POLBMAPTHCRTR2
SCHEMBL6409365 0.88 MAPT (0.41) ALDH1A1POLBMAPTROCK2ROCK1
Hydrochloric Acid SCHEMBL6417648 0.88 POLB (0.41) ALDH1A1POLBMAPTHCRTR2
Hydrochloric Acid SCHEMBL6409364 0.87 MAPT (0.40) ALDH1A1POLBMAPTROCK2ROCK1
SCHEMBL6415545 0.87 ALDH1A1 (0.47) ALDH1A1POLBL3MBTL1MAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity VIROCHEM PHARMA INC (CA) 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity CXCR1, CXCR4, CXCR2 ALDH1A1 869/4885POLB 3564/4885L3MBTL1 3554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.